Report Detail

Request for Sample of this report

Pharma & Healthcare Global GLP-1 Receptor Antagonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4612644
    • |
  • 02 September, 2024
    • |
  • Global
    • |
  • 125 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

GLP-1 receptor antagonists are a class of drugs used to treat metabolic diseases such as type 2 diabetes and obesity. They act on the GLP-1 receptor and inhibit the binding of GLP-1 to its receptor, thus blocking the biological effects of GLP-1. These drugs reduce insulin secretion by reducing the effects of GLP-1 and are often used to control blood sugar levels and weight. GLP-1 receptor antagonists are the opposite of GLP-1 receptor agonists, which are drugs that stimulate GLP-1 receptors and promote the biological effects of GLP-1.
According to our (Global Info Research) latest study, the global GLP-1 Receptor Antagonist market size was valued at US$ 3641 million in 2023 and is forecast to a readjusted size of USD 5711 million by 2030 with a CAGR of 6.6% during review period.
From the perspective of market size and growth trends, the GLP-1 drug market is growing rapidly. It has achieved great success in sales due to its excellent patient compliance. Take dulaglutide and semaglutide as examples. The global sales of these two drugs in 2022 will reach US$7.44 billion and US$9.342 billion respectively. In addition, the market value of two major pharmaceutical companies, Novo Nordisk and Eli Lilly, has soared due to the popularity of GLP-1 drugs. In the diabetes drug market, GLP-1 drugs have a market share of 39%, surpassing insulin to become the largest type of diabetes treatment drug in the world. In general, the market for GLP-1 receptor antagonists (or GLP-1 receptor agonists) is developing rapidly, and long-acting and oral administration are the main development trends in the future.
This report is a detailed and comprehensive analysis for global GLP-1 Receptor Antagonist market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global GLP-1 Receptor Antagonist market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global GLP-1 Receptor Antagonist market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global GLP-1 Receptor Antagonist market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
Global GLP-1 Receptor Antagonist market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for GLP-1 Receptor Antagonist
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global GLP-1 Receptor Antagonist market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, AstraZeneca, Sanofi, Eli Lilly, Bayer, Merck, Shionogi, Pfizer, Jiangsu Hengrui Pharmaceuticals, Shanghai Fosun Pharmaceutical (Group), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
GLP-1 Receptor Antagonist market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Injection
Oral Agent
Market segment by Application
Diabetes Treatment
Research
Other
Major players covered
Novo Nordisk
AstraZeneca
Sanofi
Eli Lilly
Bayer
Merck
Shionogi
Pfizer
Jiangsu Hengrui Pharmaceuticals
Shanghai Fosun Pharmaceutical (Group)
Shanghai Pharmaceutical Industry Research Institute
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GLP-1 Receptor Antagonist product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GLP-1 Receptor Antagonist, with price, sales quantity, revenue, and global market share of GLP-1 Receptor Antagonist from 2019 to 2024.
Chapter 3, the GLP-1 Receptor Antagonist competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GLP-1 Receptor Antagonist breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and GLP-1 Receptor Antagonist market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GLP-1 Receptor Antagonist.
Chapter 14 and 15, to describe GLP-1 Receptor Antagonist sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global GLP-1 Receptor Antagonist Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Injection
    • 1.3.3 Oral Agent
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global GLP-1 Receptor Antagonist Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Diabetes Treatment
    • 1.4.3 Research
    • 1.4.4 Other
  • 1.5 Global GLP-1 Receptor Antagonist Market Size & Forecast
    • 1.5.1 Global GLP-1 Receptor Antagonist Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global GLP-1 Receptor Antagonist Sales Quantity (2019-2030)
    • 1.5.3 Global GLP-1 Receptor Antagonist Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Novo Nordisk
    • 2.1.1 Novo Nordisk Details
    • 2.1.2 Novo Nordisk Major Business
    • 2.1.3 Novo Nordisk GLP-1 Receptor Antagonist Product and Services
    • 2.1.4 Novo Nordisk GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Novo Nordisk Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca GLP-1 Receptor Antagonist Product and Services
    • 2.2.4 AstraZeneca GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi GLP-1 Receptor Antagonist Product and Services
    • 2.3.4 Sanofi GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Eli Lilly
    • 2.4.1 Eli Lilly Details
    • 2.4.2 Eli Lilly Major Business
    • 2.4.3 Eli Lilly GLP-1 Receptor Antagonist Product and Services
    • 2.4.4 Eli Lilly GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Eli Lilly Recent Developments/Updates
  • 2.5 Bayer
    • 2.5.1 Bayer Details
    • 2.5.2 Bayer Major Business
    • 2.5.3 Bayer GLP-1 Receptor Antagonist Product and Services
    • 2.5.4 Bayer GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bayer Recent Developments/Updates
  • 2.6 Merck
    • 2.6.1 Merck Details
    • 2.6.2 Merck Major Business
    • 2.6.3 Merck GLP-1 Receptor Antagonist Product and Services
    • 2.6.4 Merck GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck Recent Developments/Updates
  • 2.7 Shionogi
    • 2.7.1 Shionogi Details
    • 2.7.2 Shionogi Major Business
    • 2.7.3 Shionogi GLP-1 Receptor Antagonist Product and Services
    • 2.7.4 Shionogi GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Shionogi Recent Developments/Updates
  • 2.8 Pfizer
    • 2.8.1 Pfizer Details
    • 2.8.2 Pfizer Major Business
    • 2.8.3 Pfizer GLP-1 Receptor Antagonist Product and Services
    • 2.8.4 Pfizer GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Pfizer Recent Developments/Updates
  • 2.9 Jiangsu Hengrui Pharmaceuticals
    • 2.9.1 Jiangsu Hengrui Pharmaceuticals Details
    • 2.9.2 Jiangsu Hengrui Pharmaceuticals Major Business
    • 2.9.3 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product and Services
    • 2.9.4 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
  • 2.10 Shanghai Fosun Pharmaceutical (Group)
    • 2.10.1 Shanghai Fosun Pharmaceutical (Group) Details
    • 2.10.2 Shanghai Fosun Pharmaceutical (Group) Major Business
    • 2.10.3 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product and Services
    • 2.10.4 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Shanghai Fosun Pharmaceutical (Group) Recent Developments/Updates
  • 2.11 Shanghai Pharmaceutical Industry Research Institute
    • 2.11.1 Shanghai Pharmaceutical Industry Research Institute Details
    • 2.11.2 Shanghai Pharmaceutical Industry Research Institute Major Business
    • 2.11.3 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product and Services
    • 2.11.4 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Shanghai Pharmaceutical Industry Research Institute Recent Developments/Updates

3 Competitive Environment: GLP-1 Receptor Antagonist by Manufacturer

  • 3.1 Global GLP-1 Receptor Antagonist Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global GLP-1 Receptor Antagonist Revenue by Manufacturer (2019-2024)
  • 3.3 Global GLP-1 Receptor Antagonist Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of GLP-1 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 GLP-1 Receptor Antagonist Manufacturer Market Share in 2023
    • 3.4.3 Top 6 GLP-1 Receptor Antagonist Manufacturer Market Share in 2023
  • 3.5 GLP-1 Receptor Antagonist Market: Overall Company Footprint Analysis
    • 3.5.1 GLP-1 Receptor Antagonist Market: Region Footprint
    • 3.5.2 GLP-1 Receptor Antagonist Market: Company Product Type Footprint
    • 3.5.3 GLP-1 Receptor Antagonist Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global GLP-1 Receptor Antagonist Market Size by Region
    • 4.1.1 Global GLP-1 Receptor Antagonist Sales Quantity by Region (2019-2030)
    • 4.1.2 Global GLP-1 Receptor Antagonist Consumption Value by Region (2019-2030)
    • 4.1.3 Global GLP-1 Receptor Antagonist Average Price by Region (2019-2030)
  • 4.2 North America GLP-1 Receptor Antagonist Consumption Value (2019-2030)
  • 4.3 Europe GLP-1 Receptor Antagonist Consumption Value (2019-2030)
  • 4.4 Asia-Pacific GLP-1 Receptor Antagonist Consumption Value (2019-2030)
  • 4.5 South America GLP-1 Receptor Antagonist Consumption Value (2019-2030)
  • 4.6 Middle East & Africa GLP-1 Receptor Antagonist Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global GLP-1 Receptor Antagonist Sales Quantity by Type (2019-2030)
  • 5.2 Global GLP-1 Receptor Antagonist Consumption Value by Type (2019-2030)
  • 5.3 Global GLP-1 Receptor Antagonist Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global GLP-1 Receptor Antagonist Sales Quantity by Application (2019-2030)
  • 6.2 Global GLP-1 Receptor Antagonist Consumption Value by Application (2019-2030)
  • 6.3 Global GLP-1 Receptor Antagonist Average Price by Application (2019-2030)

7 North America

  • 7.1 North America GLP-1 Receptor Antagonist Sales Quantity by Type (2019-2030)
  • 7.2 North America GLP-1 Receptor Antagonist Sales Quantity by Application (2019-2030)
  • 7.3 North America GLP-1 Receptor Antagonist Market Size by Country
    • 7.3.1 North America GLP-1 Receptor Antagonist Sales Quantity by Country (2019-2030)
    • 7.3.2 North America GLP-1 Receptor Antagonist Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe GLP-1 Receptor Antagonist Sales Quantity by Type (2019-2030)
  • 8.2 Europe GLP-1 Receptor Antagonist Sales Quantity by Application (2019-2030)
  • 8.3 Europe GLP-1 Receptor Antagonist Market Size by Country
    • 8.3.1 Europe GLP-1 Receptor Antagonist Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe GLP-1 Receptor Antagonist Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific GLP-1 Receptor Antagonist Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific GLP-1 Receptor Antagonist Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific GLP-1 Receptor Antagonist Market Size by Region
    • 9.3.1 Asia-Pacific GLP-1 Receptor Antagonist Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific GLP-1 Receptor Antagonist Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America GLP-1 Receptor Antagonist Sales Quantity by Type (2019-2030)
  • 10.2 South America GLP-1 Receptor Antagonist Sales Quantity by Application (2019-2030)
  • 10.3 South America GLP-1 Receptor Antagonist Market Size by Country
    • 10.3.1 South America GLP-1 Receptor Antagonist Sales Quantity by Country (2019-2030)
    • 10.3.2 South America GLP-1 Receptor Antagonist Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa GLP-1 Receptor Antagonist Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa GLP-1 Receptor Antagonist Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa GLP-1 Receptor Antagonist Market Size by Country
    • 11.3.1 Middle East & Africa GLP-1 Receptor Antagonist Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa GLP-1 Receptor Antagonist Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 GLP-1 Receptor Antagonist Market Drivers
  • 12.2 GLP-1 Receptor Antagonist Market Restraints
  • 12.3 GLP-1 Receptor Antagonist Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of GLP-1 Receptor Antagonist and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of GLP-1 Receptor Antagonist
  • 13.3 GLP-1 Receptor Antagonist Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 GLP-1 Receptor Antagonist Typical Distributors
  • 14.3 GLP-1 Receptor Antagonist Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on GLP-1 Receptor Antagonist. Industry analysis & Market Report on GLP-1 Receptor Antagonist is a syndicated market report, published as Global GLP-1 Receptor Antagonist Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of GLP-1 Receptor Antagonist market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,651.76
    		3,977.64
    		5,303.52
    		3,138.96
    		4,708.44
    		6,277.92
    		490,540.80
    		735,811.20
    		981,081.60
    		292,180.80
    		438,271.20
    		584,361.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo